Health · NZ ·

Upacicalcet Meets Primary Endpoints in Phase 3 Trials for Secondary Hyperparathyroidism

The Clinical Trial Vanguard · Health

Published

Upacicalcet Meets Primary Endpoints in Phase 3 Trials for Secondary Hyperparathyroidism

Read it at the source

The Clinical Trial Vanguard↗

We link out rather than republish. The reporting belongs to the publications above; the summary and the search data on this page are ours.

More trending now